Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Changes in Stockholders' Equity

v3.24.1
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Non-Controlling Interests
Total
Balance at Dec. 31, 2021 $ 3 $ 7 $ 656,127 $ (547,463) $ 117,203 $ 225,877
Balance (in shares) at Dec. 31, 2021 3,427,138 6,762,368        
Stock-based compensation expense     22,987     22,987
Issuance of common stock related to equity plans     174     174
Issuance of common stock related to equity plans (in shares)   327,586        
Issuance of common stock for at-the-market offering, net     6,053     6,053
Issuance of common stock for at-the-market offering, net (in shares)   276,329        
Payment of Series A perpetual preferred stock dividends     (8,031)     (8,031)
Partner company's offering, net     3,205     3,205
Partner company's at-the-market offering, net     16,370     16,370
Partner company's exercise of options for cash     142     142
Partner company's exercise of warrants for cash     148     148
Partner company's reclassification of warrant liability to equity     89     89
Partner company's repurchase of stock     (1,105)     (1,105)
Partner company's stock adjustment     (29)     (29)
Issuance of common stock under partner company's ESPP     206     206
Partner company's dividends declared and paid     (749)     (749)
Partner company's net settlement of shares withheld for taxes     (1,698)     (1,698)
Partner company's warrants issued in conjunction with debt     384     384
Partner company's retained earnings adjustment     195 (195)    
Partner company's redemption of preferred shares     (85)     (85)
Warrants           384
Non-controlling interest in partner companies     (18,439)   18,439  
Net loss attributable to non-controlling interest         (127,338) (127,338)
Net loss attributable to common stockholders       (86,575)   (86,575)
Balance at Dec. 31, 2022 $ 3 $ 7 675,944 (634,233) 8,304 50,025
Balance (in shares) at Dec. 31, 2022 3,427,138 7,366,283        
Stock-based compensation expense     17,029     17,029
Issuance of common stock related to equity plans (in shares)   224,690        
Issuance of stock for public offerings, net   $ 7 22,078     22,085
Issuance of stock for public offerings, net (in shares)   6,994,526        
Issuance of common stock for at-the-market offering, net     2,041     2,041
Issuance of common stock for at-the-market offering, net (in shares)   224,003        
Common shares issued for dividend on partner company's convertible preferred shares     266     266
Common shares issued for dividend on partner company's convertible preferred shares (in shares)   58,551        
Payment of Series A perpetual preferred stock dividends     (8,032)     (8,032)
Exercise of warrants for cash   $ 1 382     383
Exercise of warrants for cash (in shares)   225,000        
Partner company's offering, net     59,956     59,956
Partner company's at-the-market offering, net     4,620     4,620
Warrant charge in conjunction with Oaktree debt     272     272
Partner company's exercise of options for cash     121     121
Issuance of common stock under partner company's ESPP     178     178
Partner company's dividends declared and paid     (736)     (736)
Issuance of partner company's common shares for research and development expenses     1,240     1,240
Partner company's redemption of preferred shares     (400)     (400)
Warrants           0
Deconsolidation/dissolution of subsidiary non-controlling interests         6,693 6,693
Non-controlling interest in partner companies     (57,563)   57,563  
Net loss attributable to non-controlling interest         (93,517) (93,517)
Net loss attributable to common stockholders       (60,637)   (60,637)
Balance at Dec. 31, 2023 $ 3 $ 15 $ 717,396 $ (694,870) $ (20,957) $ 1,587
Balance (in shares) at Dec. 31, 2023 3,427,138 15,093,053